Correlation Between Pharvaris and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pharvaris and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharvaris BV and Edgewise Therapeutics, you can compare the effects of market volatilities on Pharvaris and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and Edgewise Therapeutics.
Diversification Opportunities for Pharvaris and Edgewise Therapeutics
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pharvaris and Edgewise is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Pharvaris i.e., Pharvaris and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between Pharvaris and Edgewise Therapeutics
Given the investment horizon of 90 days Pharvaris BV is expected to generate 1.74 times more return on investment than Edgewise Therapeutics. However, Pharvaris is 1.74 times more volatile than Edgewise Therapeutics. It trades about -0.03 of its potential returns per unit of risk. Edgewise Therapeutics is currently generating about -0.14 per unit of risk. If you would invest 2,221 in Pharvaris BV on August 24, 2024 and sell it today you would lose (117.00) from holding Pharvaris BV or give up 5.27% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pharvaris BV vs. Edgewise Therapeutics
Performance |
| Timeline |
| Pharvaris BV |
| Edgewise Therapeutics |
Pharvaris and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pharvaris and Edgewise Therapeutics
The main advantage of trading using opposite Pharvaris and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.| Pharvaris vs. Pmv Pharmaceuticals | Pharvaris vs. Eliem Therapeutics | Pharvaris vs. MediciNova | Pharvaris vs. PepGen |
| Edgewise Therapeutics vs. Lyra Therapeutics | Edgewise Therapeutics vs. Hookipa Pharma | Edgewise Therapeutics vs. Cingulate Warrants | Edgewise Therapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |